Key Highlights
- Established in 1987 to address financially distressed large and medium enterprises.
- Empowered to either rehabilitate sick firms or orderly wind them up.
- Its authority was curtailed by the SARFAESI Act (2002) and later subsumed under NCLT/NCLAT in 2016.
- Played a pivotal role in restructuring, worker‑management dispute resolution, and safeguarding industrial assets.
- Faced constraints such as limited enforcement powers, dependence on banks, and modest success rates.
Detailed Insights
The Board for Industrial and Financial Reconstruction (BIFR) was inaugurated on 15 May 1987 as a statutory mechanism to intervene when a company’s accumulated losses eclipsed its net worth, rendering it “sick.” Its charter mandated two alternative pathways: devise a rehabilitation plan that could restore profitability, or, where revival was implausible, supervise an orderly liquidation to protect creditors and workers.
Initially, BIFR operated under the Sick Industrial Companies (Special Provisions) Act, 1985, and its jurisdiction was later expanded to include public‑sector undertakings after the 1991 industrial policy reforms. The 2002 SARFAESI Act, however, stripped BIFR of several enforcement tools by granting banks the right to seize assets and recover dues without recourse to the Board, thereby diminishing its relevance.
In December 2016, the government dissolved BIFR, transferring its residual functions to the National Company Law Tribunal (NCLT) and the National Company Law Appellate Tribunal (NCLAT). This transition aimed to consolidate corporate insolvency proceedings under a unified legal framework.
Throughout its three‑decade existence, BIFR issued declarations of sickness, prescribed financial and operational restructuring measures, monitored compliance, and facilitated dialogue between management, labor unions, and financial institutions. Its achievements include the successful turnaround of several large manufacturers, the mediation of labor disputes, and the preservation of industrial assets that might otherwise have been liquidated.
Nevertheless, the Board grappled with notable limitations: it could not impose monetary penalties, relied heavily on the cooperation of banks and other agencies, possessed a modest staff complement, and often faced low recovery rates, with many declared‑sick firms ultimately winding up.